{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:31:11Z","timestamp":1791261071903,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the local funding project for scientific and technological development under the guidance of central government","award":["GuiKe ZY21195012"],"award-info":[{"award-number":["GuiKe ZY21195012"]}]},{"DOI":"10.13039\/501100018602","name":"Guangxi Innovation-Driven Development Project","doi-asserted-by":"publisher","award":["GuiKe AA18242040"],"award-info":[{"award-number":["GuiKe AA18242040"]}],"id":[{"id":"10.13039\/501100018602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11460-8","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:29:41Z","timestamp":1768393781000},"page":"5737-5758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel matrine derivative B10 exerts its anti-liver cancer activity in vitro and in vivo via targeting FGFR3\/PI3K\/AKT signaling pathway"],"prefix":"10.1007","volume":"30","author":[{"given":"Xingdong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouxing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"11460_CR1","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1021\/acs.jmedchem.6b00473","volume":"59","author":"BL DeCorte","year":"2016","unstructured":"DeCorte BL (2016) Underexplored opportunities for natural products in drug discovery. J Med Chem 59:9295\u20139304","journal-title":"J Med Chem"},{"key":"11460_CR2","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.1021\/acs.jmedchem.0c02026","volume":"64","author":"X Ren","year":"2021","unstructured":"Ren X, Xie X, Chen B, Liu L, Jiang C, Qian Q (2021) Marine natural products: a potential source of Anti-hepatocellular carcinoma drugs. J Med Chem 64:7879\u20137899","journal-title":"J Med Chem"},{"key":"11460_CR3","doi-asserted-by":"publisher","first-page":"115031","DOI":"10.1016\/j.ejmech.2022.115031","volume":"247","author":"Z Wang","year":"2023","unstructured":"Wang Z, Xiong Y, Peng Y, Zhang X, Li S et al (2023) Natural product evodiamine-inspired medicinal chemistry: anticancer activity, structural optimization and structure-activity relationship. Eur J Med Chem 247:115031","journal-title":"Eur J Med Chem"},{"key":"11460_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s11030-022-10590-7","volume":"28","author":"AP Das","year":"2024","unstructured":"Das AP, Agarwal SM (2024) Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches. Mol Divers 28:901\u2013925","journal-title":"Mol Divers"},{"key":"11460_CR5","doi-asserted-by":"publisher","first-page":"109241","DOI":"10.1016\/j.bioorg.2025.109241","volume":"167","author":"M Ma","year":"2025","unstructured":"Ma M, Cheng J, Wang J, Cao P, Wei Y et al (2025) Diversified applications and research progress of plant-derived natural products in PROTAC technology. Bioorg Chem 167:109241","journal-title":"Bioorg Chem"},{"key":"11460_CR6","doi-asserted-by":"publisher","first-page":"118282","DOI":"10.1016\/j.ejmech.2025.118282","volume":"302","author":"AE El-Haddad","year":"2026","unstructured":"El-Haddad AE, Abd El-Al MS, Teleb M, Farag MA (2026) Antidiabetic action mechanisms of saponins via gut digestive enzymes Inhibition and microbiota interaction, a comprehensive review and in Silico Docking to improve efficacy. Eur J Med Chem 302:118282","journal-title":"Eur J Med Chem"},{"key":"11460_CR7","doi-asserted-by":"crossref","unstructured":"Qin J, Zhang S, Pan Y, Lei X, Guo Z et al (2025) Progress and application of activity-based protein profiling for the discovery of natural product targets. Mol Divers","DOI":"10.1007\/s11030-025-11361-w"},{"key":"11460_CR8","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1002\/ptr.70083","volume":"39","author":"F Niazpour","year":"2025","unstructured":"Niazpour F, Meshkani R (2025) Natural products targeting ferroptosis in type 2 diabetes mellitus and its complications. Phytother Res 39:4658\u20134676","journal-title":"Phytother Res"},{"key":"11460_CR9","doi-asserted-by":"publisher","first-page":"117649","DOI":"10.1016\/j.ejmech.2025.117649","volume":"292","author":"C Liu","year":"2025","unstructured":"Liu C, Wang W, Miao R, Chen H, Wang N et al (2025) Structure optimization of natural product Piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect. Eur J Med Chem 292:117649","journal-title":"Eur J Med Chem"},{"key":"11460_CR10","doi-asserted-by":"publisher","first-page":"108482","DOI":"10.1016\/j.bioorg.2025.108482","volume":"160","author":"X Wang","year":"2025","unstructured":"Wang X, Xu T, Ou A, Hu Z, Li M et al (2025) Design, synthesis and in vitro and in vivo biological evaluation of matrine derivatives as efficient anticancer agents with the characteristics of Endoplasmic reticulum stress induction and apoptosis activation. Bioorg Chem 160:108482","journal-title":"Bioorg Chem"},{"key":"11460_CR11","doi-asserted-by":"publisher","first-page":"1656862","DOI":"10.3389\/fphar.2025.1656862","volume":"16","author":"D Meng","year":"2025","unstructured":"Meng D, Cui Z, Li L, Shang Q, Chen X (2025) Matrine in cancer therapy: antitumor mechanisms and nano-delivery strategies. Front Pharmacol 16:1656862","journal-title":"Front Pharmacol"},{"key":"11460_CR12","doi-asserted-by":"publisher","first-page":"118504","DOI":"10.1016\/j.biopha.2025.118504","volume":"191","author":"Y Xu","year":"2025","unstructured":"Xu Y, Liu H, Guo H, Zheng J, Tao L, Wu W (2025) Therapeutic potential of matrine and osthole against copper-promoted lung cancer cell malignancy. Biomed Pharmacother 191:118504","journal-title":"Biomed Pharmacother"},{"key":"11460_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12032-025-02858-3","volume":"42","author":"A Ou","year":"2025","unstructured":"Ou A, Wang X, Xu T, Hu Z, Jiang L, Wang L (2025) Design, synthesis and anti-tumor activity of matrine derivatives as Hsp90 inhibitors. Med Oncol 42:310","journal-title":"Med Oncol"},{"key":"11460_CR14","doi-asserted-by":"publisher","first-page":"115305","DOI":"10.1016\/j.bmc.2020.115305","volume":"28","author":"Y Xu","year":"2020","unstructured":"Xu Y, Jing D, Zhao D, Wu Y, Xing L et al (2020) New modification strategy of matrine as Hsp90 inhibitors based on its specific L conformation for cancer treatment. Bioorg Med Chem 28:115305","journal-title":"Bioorg Med Chem"},{"key":"11460_CR15","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.3892\/ol.2017.6475","volume":"14","author":"L Jiang","year":"2017","unstructured":"Jiang L, Wu L, Yang F, Almosnid N, Liu X et al (2017) Synthesis, biological evaluation and mechanism studies of matrine derivatives as anticancer agents. Oncol Lett 14:3057\u20133064","journal-title":"Oncol Lett"},{"key":"11460_CR16","doi-asserted-by":"publisher","first-page":"140747","DOI":"10.1016\/j.molstruc.2024.140747","volume":"1323","author":"B Zhou","year":"2025","unstructured":"Zhou B, Wei Y, Kowah JAH, Wang L, Song Y (2025) Potential VEGFR-2 inhibitors based on the molecular structures of imidazo[2,1-b]thiazole and matrine: design, synthesis, in vitro evaluation of antitumor activity and molecular docking. J Mol Struct 1323:140747","journal-title":"J Mol Struct"},{"key":"11460_CR17","doi-asserted-by":"publisher","first-page":"116348","DOI":"10.1016\/j.ejmech.2024.116348","volume":"270","author":"G Qiu","year":"2024","unstructured":"Qiu G, Xie J, Li F, Han K, Long Q et al (2024) Design, synthesis and biological evaluation of matrine contains benzimidazole derivatives as dual TOPOI and PARP inhibitors for cancer therapy. Eur J Med Chem 270:116348","journal-title":"Eur J Med Chem"},{"key":"11460_CR18","doi-asserted-by":"publisher","first-page":"107276","DOI":"10.1016\/j.bioorg.2024.107276","volume":"146","author":"G Qiu","year":"2024","unstructured":"Qiu G, Li F, Kowah JAH, Xie J, Long Q et al (2024) Novel chiral matrine derivatives as potential antitumor agents: Design, synthesis and biological evaluation. Bioorg Chem 146:107276","journal-title":"Bioorg Chem"},{"key":"11460_CR19","doi-asserted-by":"publisher","first-page":"118082","DOI":"10.1016\/j.ejmech.2025.118082","volume":"300","author":"G Shen","year":"2025","unstructured":"Shen G, Zhu Y, Li S, Xi Y, Xu Z et al (2025) Design, synthesis, and evaluation of novel matrine derivatives as topoisomerase I inhibitors for anticancer agents. Eur J Med Chem 300:118082","journal-title":"Eur J Med Chem"},{"key":"11460_CR20","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1080\/17568919.2025.2515815","volume":"17","author":"W Li","year":"2025","unstructured":"Li W, Wang H, Zhang W, Miao Z (2025) Recent developments in matrine as a versatile molecular scaffold in small molecule drug discovery. Future Med Chem 17:1337\u20131347","journal-title":"Future Med Chem"},{"key":"11460_CR21","doi-asserted-by":"crossref","unstructured":"Li J, Wei S, Marabada D, Wang Z, Huang Q (2023) Research progress of natural matrine compounds and synthetic matrine derivatives. Molecules 28","DOI":"10.3390\/molecules28155780"},{"key":"11460_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1142\/S0192415X23500283","volume":"51","author":"S Wang","year":"2023","unstructured":"Wang S, Yang S, Yang X, Deng D, Li J, Dong M (2023) Research progress of traditional Chinese medicine monomers in reversing multidrug resistance of breast cancer. Am J Chin Med 51:575\u2013594","journal-title":"Am J Chin Med"},{"key":"11460_CR23","doi-asserted-by":"publisher","first-page":"867318","DOI":"10.3389\/fchem.2022.867318","volume":"10","author":"XY Sun","year":"2022","unstructured":"Sun XY, Jia LY, Rong Z, Zhou X, Cao LQ et al (2022) Research advances on matrine. Front Chem 10:867318","journal-title":"Front Chem"},{"key":"11460_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DDDT.S349678","volume":"16","author":"Y Lin","year":"2022","unstructured":"Lin Y, He F, Wu L, Xu Y, Du Q (2022) Matrine exerts Pharmacological effects through multiple signaling pathways: a comprehensive review. Drug Des Devel Ther 16:533\u2013569","journal-title":"Drug Des Devel Ther"},{"key":"11460_CR25","doi-asserted-by":"publisher","first-page":"108161","DOI":"10.1016\/j.bioorg.2025.108161","volume":"156","author":"N Verma","year":"2025","unstructured":"Verma N, Tiwari G, Khanna A, Mishra VK, Yadav Y et al (2025) Molecular design, synthesis and anti-cancer activity of novel Pyrazolo[3,4-b]pyridine-based glycohybrid molecules. Bioorg Chem 156:108161","journal-title":"Bioorg Chem"},{"key":"11460_CR26","doi-asserted-by":"publisher","first-page":"117018","DOI":"10.1016\/j.ejmech.2024.117018","volume":"281","author":"Q Xu","year":"2025","unstructured":"Xu Q, Deng H, Huang X, Chen G-Q, Quan Y-S et al (2025) Design, synthesis, and in vitro and in vivo biological evaluation of Dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties. Eur J Med Chem 281:117018","journal-title":"Eur J Med Chem"},{"key":"11460_CR27","doi-asserted-by":"publisher","first-page":"2490707","DOI":"10.1080\/14756366.2025.2490707","volume":"40","author":"M Tian","year":"2025","unstructured":"Tian M, Zhao L, Lan Y, Li C, Ling Y, Zhou B (2025) Design, synthesis and biological evaluation of novel urolithin derivatives targeting liver cancer cells. J Enzyme Inhib Med Chem 40:2490707","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11460_CR28","doi-asserted-by":"publisher","first-page":"115026","DOI":"10.1016\/j.bmc.2019.07.042","volume":"27","author":"DIA Othman","year":"2019","unstructured":"Othman DIA, Selim KB, El-Sayed MA, Tantawy AS, Amen Y et al (2019) Design, synthesis and anticancer evaluation of new substituted Thiophene-Quinoline derivatives. Bioorg Med Chem 27:115026","journal-title":"Bioorg Med Chem"},{"key":"11460_CR29","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.2174\/1389557520666200715104555","volume":"20","author":"R Mishra","year":"2020","unstructured":"Mishra R, Kumar N, Mishra I, Sachan N (2020) A review on anticancer activities of thiophene and its analogs. Mini Rev Med Chem 20:1944\u20131965","journal-title":"Mini Rev Med Chem"},{"key":"11460_CR30","doi-asserted-by":"publisher","first-page":"104026","DOI":"10.1016\/j.bioorg.2020.104026","volume":"101","author":"PS Archna","year":"2020","unstructured":"Archna PS, Chawla PA (2020) Thiophene-based derivatives as anticancer agents: an overview on decade\u2019s work. Bioorg Chem 101:104026","journal-title":"Bioorg Chem"},{"key":"11460_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/1871520623666221221143918","volume":"23","author":"B Kaur","year":"2023","unstructured":"Kaur B, Singh G, Sharma V, Singh I (2023) Sulphur containing heterocyclic compounds as anticancer agents. Anticancer Agents Med Chem 23:869\u2013881","journal-title":"Anticancer Agents Med Chem"},{"key":"11460_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1039\/D4MD00450G","volume":"16","author":"S Thakur","year":"2025","unstructured":"Thakur S, Kumar D, Jaiswal S, Goel KK, Rawat P et al (2025) Medicinal chemistry-based perspectives on thiophene and its derivatives: exploring structural insights to discover plausible druggable leads. RSC Med Chem 16:481\u2013510","journal-title":"RSC Med Chem"},{"key":"11460_CR33","doi-asserted-by":"publisher","first-page":"e202400473","DOI":"10.1002\/cbdv.202400473","volume":"21","author":"S Maji","year":"2024","unstructured":"Maji S, Debnath B, Panda S, Manna T, Maity A et al (2024) Anticancer potential of the S-Heterocyclic ring containing drugs and its bioactivation to reactive metabolites. Chem Biodivers 21:e202400473","journal-title":"Chem Biodivers"},{"key":"11460_CR34","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1016\/j.bmcl.2018.09.008","volume":"28","author":"W Kong","year":"2018","unstructured":"Kong W, Bao Y, Ma Q, Xu H (2018) Synthesis and biological activities of novel pyrazolomatrine derivatives. Bioorg Med Chem Lett 28:3338\u20133341","journal-title":"Bioorg Med Chem Lett"},{"key":"11460_CR35","doi-asserted-by":"publisher","first-page":"106553","DOI":"10.1016\/j.phrs.2022.106553","volume":"187","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A et al (2023) Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: promises and challenges. Pharmacol Res 187:106553","journal-title":"Pharmacol Res"},{"key":"11460_CR36","doi-asserted-by":"publisher","first-page":"104788","DOI":"10.1016\/j.bioorg.2021.104788","volume":"110","author":"M Zheng","year":"2021","unstructured":"Zheng M, Liu Y, Wu C, Yang K, Wang Q et al (2021) Novel protacs for degradation of SHP2 protein. Bioorg Chem 110:104788","journal-title":"Bioorg Chem"},{"key":"11460_CR37","doi-asserted-by":"publisher","first-page":"114048","DOI":"10.1016\/j.ejmech.2021.114048","volume":"229","author":"C Zhou","year":"2022","unstructured":"Zhou C, Zhang JY, Liu HB, Tian XY, Liu Y et al (2022) Synthesis, biological evaluation and cellular localization study of fluorescent derivatives of Jiyuan Oridonin A. Eur J Med Chem 229:114048","journal-title":"Eur J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11460-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:40:04Z","timestamp":1783161604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11460-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11460"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11460-8","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}